Begin main content

Reports

We found 5863 result(s)

eculizumab (Soliris)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: eculizumab
Indications: Neuromyelitis optica spectrum disorder

  • Brand Name: Soliris
  • Manufacturer: Alexion Pharma Canada Corp.
  • Project Number: SR0640-000
  • Project Status: Pending
  • Submission Type: New Indication

teduglutide (Revestive)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: teduglutide
Indications: Short Bowel Syndrome (SBS), pediatrics

  • Brand Name: Revestive
  • Manufacturer: Shire Pharmaceuticals Ireland Limited
  • Project Number: SR0606-000
  • Project Status: Complete
  • Submission Type: New Indication

glucagon (Baqsimi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: glucagon
Indications: Severe hypoglycemic reactions

  • Brand Name: Baqsimi
  • Manufacturer: Eli Lilly Canada Inc.
  • Project Number: SR0626-000
  • Project Status: Active
  • Submission Type: New

caplacizumab (Cablivi)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: caplacizumab
Indications: Acquired thrombotic thrombocytopenic purpura (aTTP)

  • Brand Name: Cablivi
  • Manufacturer: Sanofi-Genzyme, a division of sanofi-aventis Canada Inc.
  • Project Number: SR0633-000
  • Project Status: Active
  • Submission Type: New

budesonide (Jorveza)

Last Updated: January 24, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: budesonide
Indications: Eosinophilic esophagitis, adults

  • Brand Name: Jorveza
  • Manufacturer: AVIR Pharma Inc.
  • Project Number: SR0634-000
  • Project Status: Active
  • Submission Type: New

apomorphine hydrochloride (Kynmobi)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson’s Disease

  • Brand Name: Kynmobi
  • Manufacturer: Sunovion Pharmaceuticals Canada Inc.
  • Project Number: SR0604-000
  • Project Status: Withdrawn
  • Submission Type: New

Iron (III) Isomaltoside 1000 (Monoferric)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: Iron (III) Isomaltoside 1000
Indications: iron deficiency anemia

  • Brand Name: Monoferric
  • Manufacturer: Pharmacosmos A/S
  • Project Number: SR0622-000
  • Project Status: Active
  • Submission Type: New

tafamidis (Vyndaqel)

Last Updated: January 23, 2020
Result type: Reports
Product Line: Common Drug Review
Generic Name: tafamidis
Indications: transthyretin-mediated amyloidosis

  • Brand Name: Vyndaqel
  • Manufacturer: Pfizer Canada
  • Project Number: SR0625-000
  • Project Status: Active
  • Submission Type: New